guaiacol has been researched along with Myocardial Infarction in 5 studies
Guaiacol: An agent thought to have disinfectant properties and used as an expectorant. (From Martindale, The Extra Pharmacopoeia, 30th ed, p747)
methylcatechol : Any member of the class of catechols carrying one or more methyl substituents.
guaiacol : A monomethoxybenzene that consists of phenol with a methoxy substituent at the ortho position.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zingerone pretreatment significantly (P<0." | 5.43 | Anti-inflammatory and anti-thrombotic effects of zingerone in a rat model of myocardial infarction. ( Hemalatha, KL; Stanely Mainzen Prince, P, 2016) |
| "Zingerone pretreatment revealed significant (P<0." | 1.48 | A molecular mechanism on the antiapoptotic effects of zingerone in isoproterenol induced myocardial infarcted rats. ( Hemalatha, KL; Stanely Mainzen Prince, P, 2018) |
| "Zingerone pretreatment significantly (P<0." | 1.43 | Anti-inflammatory and anti-thrombotic effects of zingerone in a rat model of myocardial infarction. ( Hemalatha, KL; Stanely Mainzen Prince, P, 2016) |
| "Pretreatment with zingerone daily for 14 days revealed significant preventive effects on the electrophoretic and biochemical parameters evaluated in isoproterenol-induced rats." | 1.42 | Preventive effects of zingerone on altered lipid peroxides and nonenzymatic antioxidants in the circulation of isoproterenol-induced myocardial infarcted rats. ( Hemalatha, KL; Prince, PS, 2015) |
| "Pretreatment with zingerone (vanillyl acetone) revealed preventive effects on tachycardia, LVH, ECG, and all the above mentioned biochemical parameters evaluated in isoproterenol induced myocardial infarcted rats." | 1.42 | A biochemical and 2, 3, 5-triphenyl tetrazolium chloride staining study on the preventive effects of zingerone (vanillyl acetone) in experimentally induced myocardial infarcted rats. ( Hemalatha, KL; Stanely Mainzen Prince, P, 2015) |
| "Pretreatment with zingerone prevented hyperlipidaemia and cardiac hypertrophy, by virtue of its antihyperlipidaemic, antihypertrophic, and reducing properties in isoproterenol-induced myocardial infarcted rats." | 1.42 | Antihyperlipidaemic, antihypertrophic, and reducing effects of zingerone on experimentally induced myocardial infarcted rats. ( Hemalatha, KL; Stanely Mainzen Prince, P, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stanely Mainzen Prince, P | 4 |
| Hemalatha, KL | 5 |
| Prince, PS | 1 |
5 other studies available for guaiacol and Myocardial Infarction
| Article | Year |
|---|---|
A molecular mechanism on the antiapoptotic effects of zingerone in isoproterenol induced myocardial infarcted rats.
Topics: Animals; Antioxidants; Apoptosis; Caspases; fas Receptor; Guaiacol; Isoproterenol; Male; Myocardial | 2018 |
Preventive effects of zingerone on altered lipid peroxides and nonenzymatic antioxidants in the circulation of isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Guaiacol; Isoproterenol; Lipid Peroxidation; Male; Myocar | 2015 |
A biochemical and 2, 3, 5-triphenyl tetrazolium chloride staining study on the preventive effects of zingerone (vanillyl acetone) in experimentally induced myocardial infarcted rats.
Topics: Adenosine Triphosphatases; Animals; Biomarkers; Coloring Agents; Disease Models, Animal; Electrocard | 2015 |
Antihyperlipidaemic, antihypertrophic, and reducing effects of zingerone on experimentally induced myocardial infarcted rats.
Topics: Animals; Cardiomegaly; Guaiacol; Hyperlipidemias; Hypolipidemic Agents; Isoproterenol; Male; Myocard | 2015 |
Anti-inflammatory and anti-thrombotic effects of zingerone in a rat model of myocardial infarction.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Disease Models, Animal; Fibrinolytic Agents; Glyceral | 2016 |